(1S,3R,6S,8R,9S,11S,12S,14S,15R,16R)-15-[(2R,5S)-5,6-dihydroxy-6-methylheptan-2-yl]-7,7,12,16-tetramethylpentacyclo[9.7.0.01,3.03,8.012,16]octadecane-6,9,14-triol
Internal ID | 274bbe88-163d-418d-84ca-9ea60b045f20 |
Taxonomy | Lipids and lipid-like molecules > Steroids and steroid derivatives > Cycloartanols and derivatives |
IUPAC Name | (1S,3R,6S,8R,9S,11S,12S,14S,15R,16R)-15-[(2R,5S)-5,6-dihydroxy-6-methylheptan-2-yl]-7,7,12,16-tetramethylpentacyclo[9.7.0.01,3.03,8.012,16]octadecane-6,9,14-triol |
SMILES (Canonical) | CC(CCC(C(C)(C)O)O)C1C(CC2(C1(CCC34C2CC(C5C3(C4)CCC(C5(C)C)O)O)C)C)O |
SMILES (Isomeric) | C[C@H](CC[C@@H](C(C)(C)O)O)[C@H]1[C@H](C[C@@]2([C@@]1(CC[C@]34[C@H]2C[C@@H]([C@@H]5[C@]3(C4)CC[C@@H](C5(C)C)O)O)C)C)O |
InChI | InChI=1S/C30H52O5/c1-17(8-9-22(34)26(4,5)35)23-19(32)15-28(7)20-14-18(31)24-25(2,3)21(33)10-11-30(24)16-29(20,30)13-12-27(23,28)6/h17-24,31-35H,8-16H2,1-7H3/t17-,18+,19+,20+,21+,22+,23+,24+,27-,28+,29+,30-/m1/s1 |
InChI Key | NNYKOYIGBZQYAI-MQGITODGSA-N |
Popularity | 4 references in papers |
Molecular Formula | C30H52O5 |
Molecular Weight | 492.70 g/mol |
Exact Mass | 492.38147475 g/mol |
Topological Polar Surface Area (TPSA) | 101.00 Ų |
XlogP | 4.60 |
Atomic LogP (AlogP) | 4.28 |
H-Bond Acceptor | 5 |
H-Bond Donor | 5 |
Rotatable Bonds | 5 |
There are no found synonyms. |
![2D Structure of (1S,3R,6S,8R,9S,11S,12S,14S,15R,16R)-15-[(2R,5S)-5,6-dihydroxy-6-methylheptan-2-yl]-7,7,12,16-tetramethylpentacyclo[9.7.0.01,3.03,8.012,16]octadecane-6,9,14-triol 2D Structure of (1S,3R,6S,8R,9S,11S,12S,14S,15R,16R)-15-[(2R,5S)-5,6-dihydroxy-6-methylheptan-2-yl]-7,7,12,16-tetramethylpentacyclo[9.7.0.01,3.03,8.012,16]octadecane-6,9,14-triol](https://plantaedb.com/storage/docs/compounds/2023/11/05d14970-86d6-11ee-a7e3-2d86682f4f5e.jpg)
Target | Value | Probability (raw) | Probability (%) |
---|---|---|---|
Human Intestinal Absorption | + | 0.9791 | 97.91% |
Caco-2 | - | 0.6822 | 68.22% |
Blood Brain Barrier | - | 0.5000 | 50.00% |
Human oral bioavailability | - | 0.5143 | 51.43% |
Subcellular localzation | Mitochondria | 0.6283 | 62.83% |
OATP2B1 inhibitior | - | 0.5741 | 57.41% |
OATP1B1 inhibitior | + | 0.8669 | 86.69% |
OATP1B3 inhibitior | + | 0.9561 | 95.61% |
MATE1 inhibitior | - | 1.0000 | 100.00% |
OCT2 inhibitior | - | 0.8750 | 87.50% |
BSEP inhibitior | - | 0.6200 | 62.00% |
P-glycoprotein inhibitior | - | 0.6246 | 62.46% |
P-glycoprotein substrate | - | 0.5384 | 53.84% |
CYP3A4 substrate | + | 0.6635 | 66.35% |
CYP2C9 substrate | + | 0.5963 | 59.63% |
CYP2D6 substrate | - | 0.7274 | 72.74% |
CYP3A4 inhibition | - | 0.8100 | 81.00% |
CYP2C9 inhibition | - | 0.7839 | 78.39% |
CYP2C19 inhibition | - | 0.7718 | 77.18% |
CYP2D6 inhibition | - | 0.9606 | 96.06% |
CYP1A2 inhibition | - | 0.7633 | 76.33% |
CYP2C8 inhibition | - | 0.6606 | 66.06% |
CYP inhibitory promiscuity | - | 0.9284 | 92.84% |
UGT catelyzed | + | 0.9000 | 90.00% |
Carcinogenicity (binary) | - | 0.8700 | 87.00% |
Carcinogenicity (trinary) | Non-required | 0.7329 | 73.29% |
Eye corrosion | - | 0.9899 | 98.99% |
Eye irritation | - | 0.9263 | 92.63% |
Skin irritation | + | 0.5100 | 51.00% |
Skin corrosion | - | 0.9284 | 92.84% |
Ames mutagenesis | - | 0.7015 | 70.15% |
Human Ether-a-go-go-Related Gene inhibition | + | 0.6483 | 64.83% |
Micronuclear | - | 0.9000 | 90.00% |
Hepatotoxicity | - | 0.6875 | 68.75% |
skin sensitisation | - | 0.7162 | 71.62% |
Respiratory toxicity | + | 0.5667 | 56.67% |
Reproductive toxicity | + | 0.9444 | 94.44% |
Mitochondrial toxicity | + | 0.9250 | 92.50% |
Nephrotoxicity | - | 0.8051 | 80.51% |
Acute Oral Toxicity (c) | III | 0.5853 | 58.53% |
Estrogen receptor binding | + | 0.7324 | 73.24% |
Androgen receptor binding | + | 0.7514 | 75.14% |
Thyroid receptor binding | + | 0.6005 | 60.05% |
Glucocorticoid receptor binding | + | 0.7342 | 73.42% |
Aromatase binding | + | 0.6979 | 69.79% |
PPAR gamma | + | 0.5319 | 53.19% |
Honey bee toxicity | - | 0.7225 | 72.25% |
Biodegradation | - | 0.7500 | 75.00% |
Crustacea aquatic toxicity | - | 0.6200 | 62.00% |
Fish aquatic toxicity | + | 0.9722 | 97.22% |
Proven Targets:
CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
---|---|---|---|---|---|
No proven targets yet! |
Predicted Targets (via Super-PRED):
CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
---|---|---|---|---|
CHEMBL253 | P34972 | Cannabinoid CB2 receptor | 99.56% | 97.25% |
CHEMBL284 | P27487 | Dipeptidyl peptidase IV | 96.22% | 95.69% |
CHEMBL6136 | O60341 | Lysine-specific histone demethylase 1 | 96.06% | 95.58% |
CHEMBL4482 | O96013 | Serine/threonine-protein kinase PAK 4 | 95.61% | 95.42% |
CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 95.04% | 96.09% |
CHEMBL3137262 | O60341 | LSD1/CoREST complex | 94.89% | 97.09% |
CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase | 93.88% | 91.11% |
CHEMBL3837 | P07711 | Cathepsin L | 92.37% | 96.61% |
CHEMBL2996 | Q05655 | Protein kinase C delta | 92.36% | 97.79% |
CHEMBL218 | P21554 | Cannabinoid CB1 receptor | 91.40% | 96.61% |
CHEMBL4026 | P40763 | Signal transducer and activator of transcription 3 | 90.33% | 82.69% |
CHEMBL2581 | P07339 | Cathepsin D | 90.20% | 98.95% |
CHEMBL238 | Q01959 | Dopamine transporter | 88.48% | 95.88% |
CHEMBL240 | Q12809 | HERG | 88.16% | 89.76% |
CHEMBL4203 | Q9HAZ1 | Dual specificity protein kinase CLK4 | 87.96% | 94.45% |
CHEMBL4660 | P28907 | Lymphocyte differentiation antigen CD38 | 87.95% | 95.27% |
CHEMBL2094135 | Q96BI3 | Gamma-secretase | 87.49% | 98.05% |
CHEMBL226 | P30542 | Adenosine A1 receptor | 87.48% | 95.93% |
CHEMBL2781 | P19634 | Sodium/hydrogen exchanger 1 | 87.22% | 90.24% |
CHEMBL5469 | Q14289 | Protein tyrosine kinase 2 beta | 87.05% | 91.03% |
CHEMBL4793 | Q86TI2 | Dipeptidyl peptidase IX | 85.81% | 96.95% |
CHEMBL1293267 | Q9HC97 | G-protein coupled receptor 35 | 85.62% | 89.34% |
CHEMBL4227 | P25090 | Lipoxin A4 receptor | 85.39% | 100.00% |
CHEMBL2179 | P04062 | Beta-glucocerebrosidase | 85.28% | 85.31% |
CHEMBL4261 | Q16665 | Hypoxia-inducible factor 1 alpha | 84.98% | 85.14% |
CHEMBL5888 | Q99558 | Mitogen-activated protein kinase kinase kinase 14 | 84.57% | 100.00% |
CHEMBL1907605 | P24864 | Cyclin-dependent kinase 2/cyclin E1 | 84.22% | 92.88% |
CHEMBL4657 | Q6V1X1 | Dipeptidyl peptidase VIII | 84.22% | 97.21% |
CHEMBL1994 | P08235 | Mineralocorticoid receptor | 84.01% | 100.00% |
CHEMBL2955 | O95136 | Sphingosine 1-phosphate receptor Edg-5 | 83.95% | 92.86% |
CHEMBL1907598 | P05106 | Integrin alpha-V/beta-3 | 83.85% | 95.71% |
CHEMBL2274 | Q9H228 | Sphingosine 1-phosphate receptor Edg-8 | 83.71% | 100.00% |
CHEMBL344 | Q99705 | Melanin-concentrating hormone receptor 1 | 83.58% | 92.50% |
CHEMBL1937 | Q92769 | Histone deacetylase 2 | 83.21% | 94.75% |
CHEMBL2007625 | O75874 | Isocitrate dehydrogenase [NADP] cytoplasmic | 83.12% | 99.00% |
CHEMBL2095194 | P08709 | Coagulation factor VII/tissue factor | 82.91% | 99.17% |
CHEMBL206 | P03372 | Estrogen receptor alpha | 82.17% | 97.64% |
CHEMBL3145 | P42338 | PI3-kinase p110-beta subunit | 81.85% | 98.75% |
CHEMBL3746 | P80365 | 11-beta-hydroxysteroid dehydrogenase 2 | 81.44% | 94.78% |
CHEMBL5608 | Q16288 | NT-3 growth factor receptor | 81.29% | 95.89% |
CHEMBL1871 | P10275 | Androgen Receptor | 81.21% | 96.43% |
CHEMBL1795139 | Q8IU80 | Transmembrane protease serine 6 | 81.06% | 98.33% |
CHEMBL4478 | Q00975 | Voltage-gated N-type calcium channel alpha-1B subunit | 80.86% | 97.14% |
CHEMBL3359 | P21462 | Formyl peptide receptor 1 | 80.44% | 93.56% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
Astragalus bungeanus |
Astragalus caucasicus |
Astragalus tragacantha |
PubChem | 13943302 |
LOTUS | LTS0239825 |
wikiData | Q104401905 |